Suministro de medicamentos exclusivos: Ruxolitinib (Jakavi), Trametinib (Mekinis), Dabrafenib (Tafinlar), Nilotinib (Tasigna), Pazopanib (Votrient) y Ceritinib (Zykadia). PNSP 5/2020

Contract type	Supplies
CPV	33600000
Awarded to	Novartis Farmaceutica, S. A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.